Chemoinformaics analysis of 13-CYCLOPENT-2-EN-1-YLTRIDECANOIC ACID
Molecular Weight | 280.452 | nRot | 13 |
Heavy Atom Molecular Weight | 248.196 | nRig | 23 |
Exact Molecular Weight | 280.24 | nRing | 1 |
Solubility: LogS | -3.893 | nHRing | 0 |
Solubility: LogP | 1.642 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 53.0014 |
nHD | 1 | BPOL | 32.9706 |
QED | 0.786 |
Synth | 4.317 |
Natural Product Likeliness | 2.17 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.418 |
Pgp-sub | 0.003 |
HIA | 0.018 |
CACO-2 | -4.97 |
MDCK | 0.0000238 |
BBB | 0.951 |
PPB | 0.803176 |
VDSS | 0.458 |
FU | 0.185113 |
CYP1A2-inh | 0.008 |
CYP1A2-sub | 0.808 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.872 |
CYP2c9-inh | 0.047 |
CYP2c9-sub | 0.139 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.246 |
CYP3a4-inh | 0.12 |
CYP3a4-sub | 0.918 |
CL | 4.051 |
T12 | 0.867 |
hERG | 0.027 |
Ames | 0.063 |
ROA | 0.525 |
SkinSen | 0.031 |
Carcinogencity | 0.196 |
EI | 0.011 |
Respiratory | 0.185 |
NR-Aromatase | 0.657 |
Antiviral | Yes |
Prediction | 0.623592 |